title: Crohn's disease revealed by a cheilitis granulomatosa with favorable evolution by perfusions of infliximab: report of a case and review of the literature.
authors.forename: Gilles
authors.initials: G
authors.lastname: Macaigne
authors.forename: Florence
authors.initials: F
authors.lastname: Harnois
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Boivin
authors.forename: Dorian
authors.initials: D
authors.lastname: Dikov
authors.forename: Gilles
authors.initials: G
authors.lastname: Ridoux
authors.forename: Sadek
authors.initials: S
authors.lastname: Cheaib
authors.forename: Claude
authors.initials: C
authors.lastname: Chayette
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003424:Crohn Disease / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D000069285:Infliximab; D008556:Melkersson-Rosenthal Syndrome / Q000188:drug therapy* / Q000209:etiology*; D010477:Perfusion; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab